Sutro BiopharmaSTRO
STRO
$3.78
3.57%
Market Cap: $310M
0
Funds holding %
of 6,710 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
107% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 28
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
2% more funds holding
Funds holding: 117 [Q1] → 119 (+2) [Q2]
9.19% less ownership
Funds ownership: 86.42% [Q1] → 77.23% (-9.19%) [Q2]
39% less capital invested
Capital invested by funds: $305M [Q1] → $185M (-$120M) [Q2]
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $91K
100% less funds holding in top 10
Funds holding in top 10: 3 [Q1] → 0 (-3) [Q2]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$12
217%
upside
Avg. target
$14
270%
upside
High target
$17
350%
upside
4 analyst ratings
4 positive
100%
0 neutral
0%
0 negative
0%
JMP Securities Reni Benjamin 27% 1-year accuracy 9 / 33 met price target | 350%upside $17 | Market Outperform Reiterated | 16 Sept 2024 |
HC Wainwright & Co. Andrew Fein 44% 1-year accuracy 72 / 162 met price target | 217%upside $12 | Buy Reiterated | 16 Sept 2024 |
Truist Securities Asthika Goonewardene 46% 1-year accuracy 11 / 24 met price target | 297%upside $15 | Buy Maintained | 16 Aug 2024 |
HC Wainwright & Co. Andrew Fein 44% 1-year accuracy 72 / 162 met price target | 217%upside $12 | Buy Reiterated | 14 Aug 2024 |
Financial journalist opinion
Based on 5 articles about STRO published over the past 30 days